These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 16481281

  • 21. A "steroid-free" tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation.
    Reggiani P, Arru M, Regazzi M, Gatti S, Molinaro MD, Caccamo L, Maggi U, Melada E, Paone G, Rossi G.
    Transplant Proc; 2005 May; 37(4):1697-9. PubMed ID: 15919435
    [Abstract] [Full Text] [Related]

  • 22. Effect of initial immunosuppression on long-term kidney transplant outcome in immunological low-risk patients.
    Michielsen LA, van Zuilen AD, Verhaar MC, Wisse BW, Kamburova EG, Joosten I, Allebes WA, van der Meer A, Baas MC, Spierings E, Hack CE, van Reekum FE, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Hilbrands LB.
    Nephrol Dial Transplant; 2019 Aug 01; 34(8):1417-1422. PubMed ID: 30561730
    [Abstract] [Full Text] [Related]

  • 23. Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine A, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days.
    Wennberg L, Song Z, Bennet W, Zhang J, Nava S, Sundberg B, Bari S, Groth CG, Korsgren O.
    Transplantation; 2001 Apr 27; 71(8):1024-33. PubMed ID: 11374396
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Defining optimal immunosuppression for islet transplantation based on reduced diabetogenicity in canine islet autografts.
    Shapiro AM, Geng Hao E, Lakey JR, Finegood DT, Rajotte RV, Kneteman NM.
    Transplantation; 2002 Dec 15; 74(11):1522-8. PubMed ID: 12490784
    [Abstract] [Full Text] [Related]

  • 26. Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and post-transplant diabetes.
    Humar A, Crotteau S, Gruessner A, Kandaswamy R, Gruessner R, Payne W, Lake J.
    Clin Transplant; 2007 Dec 15; 21(4):526-31. PubMed ID: 17645714
    [Abstract] [Full Text] [Related]

  • 27. Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival.
    Kanatani T, Lanzetta M, Owen E, Matsumoto T, Fujioka H, Kurosaka M, McCaughan GW, Bishop GA.
    Transplant Proc; 2005 Jun 15; 37(5):2382-4. PubMed ID: 15964421
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Neuroregeneration in composite tissue allografts: effect of low-dose FK506 and mycophenolate mofetil immunotherapy.
    Cottrell BL, Perez-Abadia G, Onifer SM, Magnuson DS, Burke DA, Grossi FV, Francois CG, Barker JH, Maldonado C.
    Plast Reconstr Surg; 2006 Sep 15; 118(3):615-23; discussion 624-5. PubMed ID: 16932168
    [Abstract] [Full Text] [Related]

  • 30. Efficacy of low-dose mycophenolate mofetil therapy for Taiwanese renal transplantation patients receiving primary cyclosporine immunosuppression.
    Tsai MK, Hu RH, Lee CJ, Lee PH.
    J Formos Med Assoc; 2002 Sep 15; 101(9):616-21. PubMed ID: 12645188
    [Abstract] [Full Text] [Related]

  • 31. Clinical aspects of sensitization.
    Katznelson S, Bhaduri S, Cecka JM.
    Clin Transpl; 1997 Sep 15; ():285-96. PubMed ID: 9919412
    [Abstract] [Full Text] [Related]

  • 32. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T, Mendez R, Yang HC, Weinstein S, Jensik S, Steinberg S, Prograf Study Group.
    Transplantation; 2003 Apr 27; 75(8):1213-20. PubMed ID: 12717205
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Experimental limb transplantation, part I: identification of an effective tapered triple combination immunosuppressive regime.
    Ayrout C, Lanzetta M, Chunasuwankul R, Gal A, Owen ER.
    Transplant Proc; 2004 Apr 27; 36(3):669-74. PubMed ID: 15110627
    [Abstract] [Full Text] [Related]

  • 36. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection.
    Boratyńska M, Banasik M, Patrzałek D, Klinger M.
    Ann Transplant; 2006 Apr 27; 11(2):51-6. PubMed ID: 17494290
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr 15; 61(7):1029-37. PubMed ID: 8623181
    [Abstract] [Full Text] [Related]

  • 40. Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.
    Włodarczyk Z, Wałaszewski J, Perner F, Vitko S, Ostrowski M, Bachleda P, Kokot F, Klinger M, Szenohradsky P, Studenik P, Navratil P, Asztalos L, Rutkowski B, Nagy KK, Hickey D.
    Ann Transplant; 2002 Apr 15; 7(3):28-31. PubMed ID: 12465429
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.